Stefan Baral is a physician epidemiologist and an Associate Professor in the Department of Epidemiology at the Johns Hopkins School of Public Health (JHSPH). Stefan has led epidemiological studies among key populations including men who have sex with men and sex workers in Southern, Eastern, and Western African countries as well as in Central and Southeastern Asia. Stefan acts as the Director of the Key Populations Program for the Center for Public Health and Human Rights at the JHSPH.
Josh is a clinician researcher, and divides his time between clinical work as an Infectious Diseases physician in Newcastle, and research work as a principal research fellow based at Menzies.
He completed his clinical infectious diseases training in 2004, and then worked on a PhD from 2007-2010 on the epidemiology, pathophysiology and adjunctive treatment of sepsis in the Top End of the Northern Territory (NT).
His main clinical interests are general infectious diseases, viral hepatitis, refugee health and infections in the critical care setting. His main research interests are clinical trials in the management of severe infections and epidemiology of severe bacterial infections.
Josh is the past president of the Australasian Society for Infectious Diseases (ASID) and is a career development fellow of Australia's National Health and Medical Research Council. In the 10 years since completing his PhD, he has over 140 peer-reviewed publications and an h-index of 31.
Dr. Carlos de Noronha is Associate Professor within the Department of Immunology and Microbial Disease at Albany Medical College, USA.
His research focus is in the field of Microbiology, more specifically HIV, Molecular Virology, Viral Infection, Virus Diseases, Viral Immunology, Immunology of Infectious Diseases and Emerging Infectious Diseases.
Director of the National AIDS Center, Istituto Superiore di Sanità , Rome, Italy. Co-Vice President and Member of the Presidential Committee of the AIDS National Commission, Ministry of Health. Member of the European Molecular Biology Organisation (EMBO).
Reader in Pathogen Dynamics at the University of Cambridge; formerly Adjunct Associate Professor in the Dept. of Pathology, University of California San Diego (UCSD). Graduated with a BA in Natural Sciences (1st class), Trinity College, Cambridge (1992), DPhil in Mathematical Biology, Merton College, Oxford (1996). Postdoctoral positions at Princeton University, Oxford University, University of Edinburgh and UCSD. Awards include: NATO Postdoctoral Fellowship (1996), MRC Nonclinical Training Fellowship (1997-2000), a Royal Society Wolfson Research Merit Award (2008-2013), and Thomson-Reuters Highly Cited Researcher awards in 2014, 2015, and 2016.
Dr. Gao is a Professor and Director of the Cancer Virology Program at the Hillman Cancer Center and in the Department of Microbiology and Molecular Genetics in the University of Pittsburgh School of Medicine.
Dr. Gao is an Elected Fellow of the American Academy of Microbiology. He currently serves as the Editor-In-Chief for the Journal of Medical Virology, Section Editor for PLoS Pathogens, and Academic Editor for PLoS One and PeerJ. He is also serving on the Editorial Boards of over 10 peer-reviewed journals including Journal of Virology, Journal of Antivirals & Antiretrovirals, Journal of Molecular Biomarkers and Diagnosis, Journal of Microbial & Biochemical Technology, Sarcoma Research International, Oncolytic Virotherapy, etc.
Delia Goletti MD, PhD, Infectious Diseases specialist. In 1992 she joined the Laboratory of Immunoregulation at the National Institutes of Health (chief Dr Fauci) working on HIV pathogenesis. In 1999 she joined the National Institute for Infectious Diseases in Rome. She has clinical duties on the tuberculosis (TB) clinic and responsibility of the Translational Research Unit where she works on TB pathogenesis, TB immunodiagnostic tests and impact of Heminths infection on HIV and TB disease.
Senior Lecturer in Communicable Disease Epidemiology, School of Public Health, University of Sydney; Public Health Lead and Node Leader for Mass Gathering Medicine, Marie Bashir Institute, University of Sydney; Honorary Life Fellow, St Andrew's College within the University of Sydney; Senior Member and College Research Associate, Wolfson College, University of Cambridge
Biographical details:
I studied medicine in Cambridge and during my junior doctor years was very interested in both neurology and infectious diseases. Clinically I specialised in medical microbiology, keeping a particular interest in neurological infections. For the past 3 years I have been in Saudi Arabia developing a pathogen genomics laboratory where I have gained first-hand experience of second generation sequencing and bioinformatics.
Research interests:
Infectious diseases and medical microbiology are undergoing the most significant shift since PCR was introduced. By the end of this decade, sequencing will have become the main option when investigating any outbreak or infection. I study the interface between genomics as a pure science and its translation into clinical and public health benefits.
At present I am examining the worldwide genomics of tuberculosis, the use of sequencing to characterise MRSA strains and the genomic variations in BCG vaccine strains used around the globe.
PhD = cloning and characterizing potential vaccine antigens from schistosomes; first postdoc = fine details of HIV replication (with David Harrich); second postdoc = best ignored; third postdoc = role of Max network, especially Mnt, in cancer and development (with Peter Hurlin). After that I made HIV POC tests and other diagnostic devices in two small biotech companies. Now I'm a research manager with Canon US Life Sci.
Professor Leondios Kostrikis is a Professor at University of Cyprus. He received his B.Sc. and Ph.D. degrees from New York University and his post-doctoral training at the Aaron Diamond AIDS Research Center of Rockefeller University. He joined the Rockefeller University as an Assistant Professor in 1999 and the University of Cyprus as Professor in 2003. He was a Fulbright, Elizabeth Glazer Pediatric AIDS Foundation and Aaron Diamond Foundation scholar. He has directed over twenty competitive grants from the NIH and the European Commission and he is an Editorial Board member for eleven international journals.
Dr. Andreas Leiherer is Co-Chair of Basic and Molecular Research, and Associate Professor within the Molecular Biology Laboratory at the Vorarlberg Institute for Vascular Investigation (VIVIT) , Austria.
His research interests include Molecular Biology, Diabetes, Atherosclerosis, Insulin Resistance, HIV, Metabolism, Infection, Metabolic Diseases, and Nutrition.
My research aims at understanding the eco-evolutionary pathways that lead to emergence and dispersal of zoonotic and human pathogens, with emphasis on land use and climate change, within the One Health approach. I employ genomics, metagenomics and phylodynamics as tools to elucidate the evolutionary processes and population dynamics that shape viral genetic diversity both at the inter-host (epidemics) and in intra-host level (individual infections).